How pharmacogenomics might help addiction treatment
How pharmacogenomics might help addiction treatment Naltrexone Molecule 20 years ago, scientists got hooked on a single transcription factor that responds to a number of drugs of abuse. Will their work lead to treatments? By Kerry Grens Related Articles 1 In 2003 David Oslin and Charles O'Brien at the University of Pennsylvania's Center for Addiction Treatment and their colleagues reported an association between this SNP and how well patients responded to naltrexo

Jun 1, 2007
How pharmacogenomics might help addiction treatment

Naltrexone Molecule
20 years ago, scientists got hooked on a single transcription factor that responds to a number of drugs of abuse. Will their work lead to treatments?
Interested in reading more?

Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?